|
|
Clinical effect of Donepezil combined with Idebenone in the treatment of early vascular cognitive dysfunction |
JI Lili HUANG Tingting▲ |
Department of Neurology, Changzhou Wujin People’s Hospital, Jiangsu Province, Changzhou 213017, China |
|
|
Abstract Objective To investigate the clinical effect of Donepezil combined with Idebenone in the treatment of early vascular cognitive dysfunction. Methods A total of 94 patients with early vascular cognitive dysfunction admitted to Changzhou Wujin People’s Hospital, Jiangsu Province from January to December 2019 were selected as the research objects. According to the random number table method, all the enrolled patients were divided into observation group and control group, with 47 cases in each group. The control group was given Donepezil routine treatment, the observation group on the basis of the control group combined with Idebenone. The two groups were compared before and after treatment with a simple mental state examination (MMSE) score, clinical efficacy, daily living activity assessment scale (ADL) score, and adverse drug reactions. Results The total clinical effective rate in the observation group was higher than that in the control group (P < 0.05). The overall analysis of MMSE score showed that the differences in intergroup comparison, time point comparison and interaction were statistically significant (all P < 0.05). Intra-group comparison: MMSE scores of both groups were significantly higher than those before treatment at 30 and 60 days after treatment, and those at 60 days after treatment were higher than those at 30 days after treatment (all P < 0.05). Comparison between groups: 30 and 60 days after treatment, MMES score of the observation group was higher than that of the control group (all P < 0.05). The overall analysis of ADL score showed that the differences in intergroup comparison, time point comparison and interaction were statistically significant (all P < 0.05). Intra-group comparison: ADL scores of the two groups were significantly higher than those before treatment at 30 and 60 days after treatment (all P < 0.05). Comparison between groups: 30 and 60 days after treatment, ADL score of the observation group was higher than that of the control group (all P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups after treatment (P > 0.05). Conclusion Donepezil combined with Idebenone is effective in the treatment of early vascular cognitive dysfunction, and can effectively improve the cognitive impairment of patients.
|
|
|
|
|
[1] 周邑东,袁怀武,计仁杰,等.缺血性卒中后应激性高血糖与早期血管性认知功能障碍的相关性[J].中国医学科学院学报,2017,39(6):749-755.
[2] 王若丹,李国春.健脑灵片联合复方银杏通脉口服液治疗血管性认知障碍45例[J].中国实验方剂学杂志,2015, 20(19):181-184.
[3] 任剑羽,牛秀茹,孙佳,等.非痴呆型血管性认知功能障碍的研究进展[J].中西医结合心脑血管病杂志,2015,13(2):207-210.
[4] 庞海云,穆景颂,倪朝民,等.强化视频互动训练对脑卒中后非痴呆型血管性认知功能障碍患者的影响[J].中国全科医学,2016,19(27):3371-3374.
[5] Barone FC,Gustafson D,Crystal HA,et al. First translational‘Think Tank’ on cerebrovascular disease, cognitive impairment and dementia [J]. J Transl Med,2016,14:50.
[6] 王东枝.丁苯酞联合奥拉西坦治疗轻度血管性认知功能障碍的有效性和安全性[J].中国医药导报,2016,13(29):52-55.
[7] 陈美英,张斌.《精神障碍诊断与统计手册第五版》双相障碍分类和诊断标准的循证依据[J].中华脑科疾病与康复杂志,2014,4(4):207-211.
[8] 蔡业峰,贾真,张新春,等.美国国立卫生院卒中量表(NIHSS)中文版多中心测评研究——附537例缺血中风多中心多时点临床测评研究[J].北京中医药大学学报,2008,31(7):494-498.
[9] Zamboni G,Griffanti L,Jenkinson M,et al. White matter imaging correlates of early cognitive impairment detected by the montreal cognitive assessment after transient ischemic attack and minor stroke [J]. Stroke,2017,48(6):1539-1547.
[10] 霍江涛,张小乔,严洁,等.美金刚联合多奈哌齐治疗中重度阿尔茨海默病的效果观察[J].中国综合临床,2015, 31(11):75-77.
[11] 王红霞.养血清脑颗粒联合盐酸多奈哌齐对脑卒中后认知障碍病人认知功能及日常生活能力的影响[J].中西医结合心脑血管病杂志,2019,6(10):1558-1559.
[12] 蔡鸣凡,周亮.艾地苯醌联合尼莫地平治疗血管性痴呆的疗效观察[J].新医学,2015,46(7):471-474.
[13] Calhoun A,King C,Khoury R,et al. An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease [J]. Expert Opin Pharmacother,2018,19(15):1711-1717.
[14] 金钱倩,经屏,张玲.丁苯肽联合艾地苯醌对血管性痴呆患者丘脑葡萄糖代谢与血管内皮细胞功能的影响[J].医学临床研究,2018,35(6):612-616
[15] 王康锋,张立娟,陈新勇.电针大椎及百会穴治疗老年性痴呆36例临床观察[J].中华中医药杂志,2015,19(3):784-786.
[16] 李知莲,吴慧芳.艾地苯醌治疗对缺血性脑卒中后抑郁患者血清学指标的影响[J].海南医学院学报,2015,21(2):262-264.
[17] 张轩,薛蓉,陈书丽,等.舒脑欣滴丸对非痴呆型血管性认知功能障碍患者神经认知的影响[J].中华神经医学杂志,2016,15(1):75-80.
[18] 刘怀翔,谈晓牧,刘建国,等.蛋氨酸负荷试验对判断脑梗死后轻度血管性认知功能障碍的价值[J].中华老年医学杂志,2015,34(10):1084-1087.
[19] 何予工,周青.重复经颅磁刺激对非痴呆型血管性认知功能障碍的影响[J].中华物理医学与康复杂志,2017, 39(6):464-466.
[20] 宓特,屈传强,王翔,等.不同部位急性脑梗死的认知功能障碍特点分析[J].中华医学杂志,2016,96(15):1205-1207.
[21] 李慧英,蒋初明,高永红,等.急性脑梗死早期认知功能与脑血流灌注相关关系的临床分析[J].中华老年心脑血管病杂志,2015,7(4):385-388.
[22] 袁俊亮,李譞婷,王双坤,等.脑小血管病与认知功能障碍[J].中华行为医学与脑科学杂志,2018,27(3):285-288.
[23] 刘超,宋亚雪,孟彦宏,等.早期认知功能评估对急性缺血性脑卒中后3~6个月认知功能的预测作用[J].中华行为医学与脑科学杂志,2019,28(1):17-23.
[24] 陈卓,张英,王海燕,等.重复经颅磁刺激联合镜像神经元训练系统对非痴呆性血管性认知障碍的影响[J].中华物理医学与康复杂志,2018,40(12):891.
[25] 王向明,陆学胜,许敏,等.脑血管病与血管性认知障碍的相关性分析[J].中西医结合心脑血管病杂志,2016, 14(20):2448-2449. |
|
|
|